Intra-Abdominal Abscess Management

Clinical Decision-Making Framework

The American College of Surgeons and Infectious Diseases Society of America recommend stopping antibiotics after 4-7 days without repeat imaging for patients showing appropriate clinical response, with key indicators including normalization of temperature, resolution of abdominal pain and tenderness, normalization of white blood cell count, declining C-reactive protein and procalcitonin levels, and return of gastrointestinal function 1, 2, 3
The Italian guidelines (2024) specifically recommend 4 days of antibiotics for immunocompetent, non-critically ill patients with adequate source control, and up to 7 days for immunocompromised or critically ill patients 1
The SIS/IDSA guidelines support 4-7 days of therapy when source control is adequate, with longer durations not associated with improved outcomes 2, 3

Clinical improvement should be evident within 3-5 days after percutaneous drainage, with decreased drainage output 7
CT with water-soluble contrast through the drainage catheter can be performed before catheter removal to confirm no residual cavity exists, but this is done to guide catheter management, not to determine antibiotic duration 9

Routine "test of cure" imaging is not recommended in clinically improved patients, as it adds unnecessary cost and radiation exposure without improving outcomes 1, 2, 3
Antibiotics should not be continued beyond 7 days simply because imaging shows residual fluid or inflammatory changes, as these findings lag behind clinical improvement 1, 2

The strongest evidence comes from the 2024 Italian guidelines and the SIS/IDSA recommendations, both emphasizing clinical resolution over radiographic resolution as the endpoint for antibiotic therapy 1, 2, 3
A prospective trial demonstrated that fixed-duration therapy of approximately 4 days produced outcomes similar to extended courses when source control was adequate 10, 8